389030GENINUS389030 info
$1.13info2.74%24h
Global rank26827
Market cap$37.41M
Change 7d-
YTD Performance-43.36%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    GENINUS (389030) Stock Overview

    GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea. It offers CancerSCAN, an NGS-based cancer genome diagnosis solution; LiquidSCAN, a liquid biopsy NGS test; and Celinus, a single-cell analysis solution for ultra-precise genome analysis. The company also provides HealthSCAN, a genetic test service; WithMe, a service that analyzes gut bacteria characteristics related to the risk of chronic diseases; and OncoSTATION, an automated clinical genome information analysis solution. It serves hospitals, pharmaceutical companies, and researchers. The company was incorporated in 2018 and is based in Seoul, South Korea.

    389030 Stock Information

    Symbol
    389030
    Address
    KDU TowerSeoul, 05836South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://kr-geninus.com
    Country
    πŸ‡°πŸ‡· South Korea
    Phone Number
    82 2 6949 6570

    GENINUS (389030) Price Chart

    -
    Value:-

    GENINUS Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.13
    N/A
    Market Cap
    $37.41M
    N/A
    Shares Outstanding
    33.13M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org